Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valeo Pharma Inc T.VPH

Alternate Symbol(s):  T.VPH.DB | VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


TSX:VPH - Post by User

Post by FOMOalphaon Dec 09, 2020 12:37am
216 Views
Post# 32065033

Been holding a position for a while and I added more today

Been holding a position for a while and I added more todayBack in last year september, I started a position of decent size in VPH at around 30 cent per share. See my previous post on the VPH bull board below:

https://stockhouse.com/companies/bullboard?symbol=c.vph&postid=30168798

Of course, I sold half of my original positions for huge (100%+) gains  later on but I am still holding a good chunk of free shares and today, I just added back more to average up my cost basis because I can sense something is brewing by the price action.  I've been witnessing the growth of this company for over a year and now I am seeing the great secular growth propects of this little monster are emerging. 

Here's my investment thesis:


1. Great story and great fundamental prospects.  As a small pharma company, their average YoY revenue growth of around 50% has been decent IMO and look at their list of products marketed in canada and internatioanlly:

https://www.valeopharma.com/our-products/ 

Even if I just focus on their products for treating Parkinson's disease, the potential is very massivehere.  There are roughly 4 million people living with parkison's disease and as we know it is chronic disease. If my napkin math is correct,if they can capture even only a tiny 2% of the market share, that would be an estimate of roughly 100M or even 200M precurring revenue per year in the future. Given that they are now trading at a market cap of 81.38 million, this means the company trading at a huge discount given their fundamental prospects. 

2. Nice share structure:  I love thin stock and roughly 70% of the shares locked by insiders here. So effectively their free float is only 18M or even less. It can make huge move easily if it attracts interest from the big money.

3. When I saw some big buyers smash the 1.20 big asks and buy aggressively today, I simply trust my own instinct and experience as a veteran investor and added a pile of shares to average up.  Something is brewing here and I have no idea what it is as a small retail investor but I will be interested in seeing the development of this company and how it escalates in the future.

Given that pharma company usually trades at a price to sale ratio around 5,  I believe we'll see VPH trade around a market cap of  400 million CAD in the future. My ideal price target for VPH is therefore $5.


<< Previous
Bullboard Posts
Next >>